Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003335
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Case Comprehensive Cancer Center 44
Not applicableEnded earlyNCT03723863
What this trial is testing

Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIIBreast Cancer Stage II+6 more
University of Washington 15
Early research (Phase 1)Study completedNCT02611063
What this trial is testing

Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant

Who this might be right for
Hematological Malignancies
Stefanie Sarantopoulos, MD, PhD. 22
Very early researchStudy completedNCT03358563
What this trial is testing

Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 30
Early research (Phase 1)Study completedNCT00006221
What this trial is testing

BMS-247550 in Treating Patients With Advanced Cancers

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 54
Large-scale testing (Phase 3)Looking for participantsNCT06296706
What this trial is testing

A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

Who this might be right for
Gastric Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 630
Testing effectiveness (Phase 2)Study completedNCT01138904
What this trial is testing

FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)

Who this might be right for
Gastric Cancer
Dong-A University Hospital 80
Early research (Phase 1)Study completedNCT05225584
What this trial is testing

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

Who this might be right for
Non Hodgkin Lymphoma (NHL)Peripheral T-cell Lymphoma (PTCL)Cutaneous T-Cell Lymphoma (CTCL)+3 more
Kymera Therapeutics, Inc. 56
Testing effectiveness (Phase 2)Temporarily pausedNCT06211933
What this trial is testing

Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS)

Who this might be right for
Non-Resectable Pancreas Carcinoma
Centre Leon Berard 26
Early research (Phase 1)Study completedNCT00005633
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT03013933
What this trial is testing

Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Recurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
City of Hope Medical Center 29
Not applicableStudy completedNCT03305133
What this trial is testing

Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC)

Who this might be right for
Large Cell Lung CancerNeuroendocrine Carcinoma of Lung (Diagnosis)
Groupe Francais De Pneumo-Cancerologie 86
Not applicableEnded earlyNCT01517347
What this trial is testing

Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

Who this might be right for
Leukemia
Peking University People's Hospital 90
Early research (Phase 1)Ended earlyNCT02919449
What this trial is testing

Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab

Who this might be right for
Recurrent Non-Small Cell Lung Cancer
Vyriad, Inc. 2
Early research (Phase 1)Study completedNCT00992758
What this trial is testing

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 11
Not applicableStudy completedNCT01706185
What this trial is testing

Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer

Who this might be right for
Neoplasms, Urinary Bladder
GlaxoSmithKline 156
Testing effectiveness (Phase 2)Looking for participantsNCT07309185
What this trial is testing

Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy

Who this might be right for
Stomach Neoplasms
Shandong Tumor Hospital 66
Not applicableUnknownNCT03709485
What this trial is testing

Evaluation of Gut Microbiome in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Ziv Hospital 150
Large-scale testing (Phase 3)Study completedNCT00212615
What this trial is testing

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
C04.588.274.476.411.307
Odense University Hospital 116
Testing effectiveness (Phase 2)Study completedNCT00020735
What this trial is testing

Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Joel Nelson, MD 45
Next Page